Medicare is now covering some GLP-1 weight loss drugs for $50. Here’s what to know
Summary
Starting March 2024, Medicare is offering a temporary program to cover certain GLP-1 weight loss drugs for $50 a month for some older adults. The program runs until the end of 2027 and targets people with specific weight and health conditions.Key Facts
- The program is called Medicare GLP-1 Bridge.
- It covers certain brand-name GLP-1 drugs approved for weight loss, like Wegovy and Foundayo.
- To qualify, people must have Medicare drug coverage and meet BMI criteria (BMI of 35 or higher, or 27+ with another health issue).
- The cost for participants is $50 monthly, but this payment does not count toward insurance deductibles or limits.
- People who already get GLP-1 drugs for other diseases like diabetes or sleep apnea are not eligible for this program.
- The program lasts until December 31, 2027, as permanent coverage by Medicare hasn’t been authorized by Congress.
- Beneficiaries must get a prescription and prior authorization from their healthcare provider to join.
- Medicare hopes to gather data from this trial to possibly support longer-term coverage in the future.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.